Advertisement

Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression

      Posttraumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder associated with high degrees of comorbidity (e.g., major depressive disorder; MDD), poor quality of life, and significant social and occupational dysfunction [
      • Shalev A.
      • Liberzon I.
      • Marmar C.
      Post-Traumatic stress disorder.
      ]. Currently available evidence-based pharmacological and psychological treatments for PTSD have only modest efficacy [
      • Watts B.V.
      • Schnurr P.P.
      • Mayo L.
      • Young-Xu Y.
      • Weeks W.B.
      • Friedman M.J.
      Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.
      ], and thus further research is necessary to develop novel approaches that can reduce symptoms in patients with this real-world comorbidity.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Shalev A.
        • Liberzon I.
        • Marmar C.
        Post-Traumatic stress disorder.
        N Engl J Med. 2017; 376: 2459-2469
        • Watts B.V.
        • Schnurr P.P.
        • Mayo L.
        • Young-Xu Y.
        • Weeks W.B.
        • Friedman M.J.
        Meta-analysis of the efficacy of treatments for posttraumatic stress disorder.
        J Clin Psychiatry. 2013; 74: e541-e550
        • O'Reardon J.P.
        • Solvason H.B.
        • Janicak P.G.
        • Sampson S.
        • Isenberg K.E.
        • Nahas Z.
        • et al.
        Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
        Biol Psychiatry. 2007; 62: 1208-1216
        • George M.S.
        • Lisanby S.H.
        • Avery D.
        • McDonald W.M.
        • Durkalski V.
        • Pavlicova M.
        • et al.
        Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
        Arch Gen Psychiatr. 2010; 67: 507-516
        • Kozel F.A.
        • Van Trees K.
        • Larson V.
        • Phillips S.
        • Hashimie J.
        • Gadbois B.
        • et al.
        One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial.
        Psychiatr Res. 2019; 273: 153-162
        • Kozel F.A.
        • Motes M.A.
        • Didehbani N.
        • DeLaRosa B.
        • Bass C.
        • Schraufnagel C.D.
        • et al.
        Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial.
        J Affect Disord. 2018; 229: 506-514
        • Carpenter L.L.
        • Conelea C.
        • Tyrka A.R.
        • Welch E.S.
        • Greenberg B.D.
        • Price L.H.
        • et al.
        5 Hz Repetitive transcranial magnetic stimulation for posttraumatic stress disorder comorbid with major depressive disorder.
        J Affect Disord. 2018; 235: 414-420
        • Philip N.S.
        • Barredo J.
        • van ‘t Wout-Frank M.
        • Tyrka A.R.
        • Price L.H.
        • Carpenter L.L.
        Network mechanisms of clinical response to transcranial magnetic stimulation in posttraumatic stress disorder and major depressive disorder.
        Biol Psychiatry. 2018; 83: 263-272
        • Koek R.J.
        • Roach J.
        • Athanasiou N.
        • van ‘t Wout-Frank M.
        • Philip N.S.
        Neuromodulatory treatments for post-traumatic stress disorder (PTSD).
        Prog Neuro-Psychopharmacol Biol Psychiatry. 2019; 92: 148-160
        • Leuchter A.F.
        • Cook I.A.
        • Feifel D.
        • Goethe J.W.
        • Husain M.
        • Carpenter L.L.
        • et al.
        Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment for major depression.
        Brain Stimul. 2015; 8: 787-794
        • Philip N.S.
        • Leuchter A.F.
        • Cook I.A.
        • Massaro J.
        • Goethe J.W.
        • Carpenter L.L.
        Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder.
        Depress Anxiety. 2019; 36: 278-285
        • Weathers F.W.
        • Litz B.T.
        • Keane T.M.
        • Palmieri P.A.
        • Marx B.P.
        • Schnurr P.P.
        The PTSD checklist for DSM-5 (PCL-5).
        2013 (scale available from: the National Center for PTSD at)
        • Rush A.J.
        • Bernstein I.H.
        • Trivedi M.H.
        • Carmody T.J.
        • Wisniewski S.
        • Mundt J.C.
        • et al.
        An evaluation of the Quick inventory of depressive symptomatology and the Hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
        Biol Psychiatry. 2006; 59: 493-501
        • Kraemer H.C.
        • Kupfer D.J.
        Size of treatment effects and their importance to clinical research and practice.
        Biol Psychiatry. 2006; 59: 990-996
        • Karsen E.F.
        • Watts B.V.
        • Holtzheimer P.E.
        Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder.
        Brain Stimul. 2014; 7: 151-157
        • Philip N.S.
        • Barredo J.
        • Aiken E.
        • Larson V.
        • Shea M.T.
        • Greenberg B.G.
        • van’t Wout-Frank M.
        Theta burst stimulation for posttraumatic stress disorder.
        Am J Psychiatry. 2019; https://doi.org/10.1176/appi.ajp.2019.18101160